These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 2278725)
1. Determination of a suitable dosage of lysine-vasopressin and triglycyl-lysine-vasopressin, given in a gel-solution locally in the rectum of rats for possible radioprotective purposes. Bjelkengren G Acta Oncol; 1990; 29(8):1041-6. PubMed ID: 2278725 [TBL] [Abstract][Full Text] [Related]
2. Radioprotective effect of local administration of lysine-vasopressin and triglycyl-lysine-vasopressin on the rectal mucosa in rats. Bjelkengren G; Aronsen KF; Augustsson NE; Borgström S; Lindström C; Nylander G Acta Oncol; 1995; 34(4):487-92. PubMed ID: 7605656 [TBL] [Abstract][Full Text] [Related]
3. Comparison of vasopressin and triglycyl-lysine vasopressin on splanchnic and systemic hemodynamics in dogs. Blei AT; Groszmann RJ; Gusberg R; Conn HO Dig Dis Sci; 1980 Sep; 25(9):688-94. PubMed ID: 7418592 [TBL] [Abstract][Full Text] [Related]
4. Uterine effects of N-alpha-triglycyl-(8-lysine)-vasopressin and 8-lysine-vasopressin in the first trimester of pregnancy. Laudański T; Akerlund M Contraception; 1980 Aug; 22(2):199-208. PubMed ID: 7449382 [TBL] [Abstract][Full Text] [Related]
5. Antidiuretic activity of terlipressin (triglycyl-lysine vasopressin)--role of pressure natriuresis. Machová A Physiol Res; 1992; 41(2):121-7. PubMed ID: 1286075 [TBL] [Abstract][Full Text] [Related]
6. Comparison between lysine vasopressin and a long-acting analogue (N alpha-triglycyl-lysine vasopressin) used as local hemostatic agents for conization. Rundqvist E; Allen D; Larsson G Acta Obstet Gynecol Scand; 1988; 67(4):301-5. PubMed ID: 3051878 [TBL] [Abstract][Full Text] [Related]
7. Terlipressin: vasopressin analog and novel drug for septic shock. Pesaturo AB; Jennings HR; Voils SA Ann Pharmacother; 2006 Dec; 40(12):2170-7. PubMed ID: 17148649 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of terlipressin after single i.v. doses to healthy volunteers. Nilsson G; Lindblom P; Ohlin M; Berling R; Vernersson E Drugs Exp Clin Res; 1990; 16(6):307-14. PubMed ID: 2086166 [TBL] [Abstract][Full Text] [Related]
9. Effect of triglycyl-lysine-vasopressin on skin blood flow and blood loss during wound excision in patients with burns. Garner WL; Thomson PD; Moore NP; Rodriguez JL; Smith DJ J Burn Care Rehabil; 1993; 14(4):458-60. PubMed ID: 8408173 [TBL] [Abstract][Full Text] [Related]
10. Controlled trial of terlipressin ('Glypressin') versus vasopressin in the early treatment of oesophageal varices. Freeman JG; Cobden I; Lishman AH; Record CO Lancet; 1982 Jul; 2(8289):66-8. PubMed ID: 6123808 [TBL] [Abstract][Full Text] [Related]
11. Effects of glypressin on human nasal mucosa. Bende M; Bake B; Flisberg K; Löth S; Ohlin P; Olsson P; Pipkorn U Acta Otolaryngol; 1986; 102(5-6):488-93. PubMed ID: 3788547 [TBL] [Abstract][Full Text] [Related]
12. The effect of triglycyl-lysine-vasopressin (terlipressin INN, Glypressin) on skin blood flow, measured with laser Doppler flowmetry, thermography and plethysmography. A dose-response study. Nilsson G; Lindblom P; Palmer B; Vernersson E; Aberg M Scand J Plast Reconstr Surg Hand Surg; 1987; 21(2):149-57. PubMed ID: 2961054 [TBL] [Abstract][Full Text] [Related]
13. Regional and systemic haemodynamic effects of some vasopressins: structural features of the hormone which prolong activity. Cort JH; Albrecht I; Nováková J; Mulder JL; Jost K Eur J Clin Invest; 1975 Apr; 5(2):165-75. PubMed ID: 168085 [TBL] [Abstract][Full Text] [Related]
14. Triglycyl-lysine-vasopressin or lysine-vasopressin in early excision of burns. An experimental study comparing the effects on blood loss, hemodynamics and renal function. Vernersson E; Palmer B; Aberg M Scand J Plast Reconstr Surg; 1984; 18(3):285-90. PubMed ID: 6528231 [TBL] [Abstract][Full Text] [Related]
15. Control of hemorrhage during renal failure with triglycyl-lysine-vasopressin. Garner WL; Rodriguez JL; Thomson PD; Brosius FC; Smith DJ Ann Plast Surg; 1993 Jul; 31(1):78-81. PubMed ID: 8357224 [TBL] [Abstract][Full Text] [Related]
16. Clinical review: Vasopressin and terlipressin in septic shock patients. Delmas A; Leone M; Rousseau S; Albanèse J; Martin C Crit Care; 2005 Apr; 9(2):212-22. PubMed ID: 15774080 [TBL] [Abstract][Full Text] [Related]
17. Terlipressin, a vasoactive prodrug recommended in hepatorenal syndrome, is an agonist of human V1, V2 and V1B receptors: Implications for its safety profile. Colson PH; Virsolvy A; Gaudard P; Charrabi A; Corbani M; Manière MJ; Richard S; Guillon G Pharmacol Res; 2016 Nov; 113(Pt A):257-264. PubMed ID: 27586252 [TBL] [Abstract][Full Text] [Related]
19. A controlled study of glypressin versus vasopressin in the control of bleeding from oesophageal varices. Chiu KW; Sheen IS; Liaw YF J Gastroenterol Hepatol; 1990; 5(5):549-53. PubMed ID: 1966593 [TBL] [Abstract][Full Text] [Related]
20. Potentiation of the classic ovine corticotrophin releasing hormone stimulation test by the combined administration of small doses of lysine vasopressin. Favrod-Coune C; Raux-Demay MC; Proeschel MF; Bertagna X; Girard F; Luton JP Clin Endocrinol (Oxf); 1993 Apr; 38(4):405-10. PubMed ID: 7686454 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]